ACC 2019

ACC 2019: PANACHE: Safety and Efficacy of Neladenoson Bialanate, a Partial Adenosine A1 Receptor Agonist, in Patients with Heart Failure and Preserved Ejection Fraction: Results from the PANACHE Randomized Controlled Trial

Drs. Daaboul and Shah discuss the results of the PANACHE Trial presented at ACC 2019

We Recommend